期刊文献+

LC-MS/MS法分析复方缬沙坦氨氯地平片中的有关物质 被引量:3

Identification of the related substances in valsartan amlodipine tablets by LC-MS /MS
下载PDF
导出
摘要 目的采用LC-MS/MS法对复方缬沙坦氨氯地平片中有关物质进行定性分析。方法采用Thermosyncronis C18色谱柱(250mm×4.6mm,5μm),以20mmol/L的醋酸铵溶液-乙腈为流动相进行梯度洗脱。采集有关物质的PDA谱、质谱母离子及子离子谱,并进行解析,推测有关物质的结构。结果在所建立的条件下,复方缬沙坦氨氯地平片中有关物质分离良好,检测出11个有关物质。结论本文建立的LC-MS/MS法可有效地分离分析复方缬沙坦氨氯地平片中的有关物质,并为其质量控制和工艺优化提供了技术参考。 Objective To establish the identification of the related substances in valsartan amlodipine tablets by LC-MS/MS method. Methods High pressure/performance liquid chromatography (HPLC) separation was carried out on Thermo syncronis C column (250 mm×4.6mm,5μm) with a gradient elution with a mobile phase consisting of 20 mmol/L ammonium acetate and pure acetonitrile. The PDA,parent ions and the corresponding product ions spectra of all the related substances in valsartan amlodipine tablets were determined. Results Good resolution of valsartan and amlodipine and their main related substances were achieved. Eleven related substances in valsartan amlodipine tablets were detected by LC-MS/MS. Conclusion The established method is effective in the separation and identification of the related substances in valsartan amlodipine tablets and the results are useful for its quality control.
出处 《新疆医科大学学报》 CAS 2013年第5期611-617,622,共8页 Journal of Xinjiang Medical University
关键词 复方缬沙坦氨氯地平片 有关物质 液相色谱串联质谱法 分离 鉴别 valsartan amlodipine tablets related substances LC-MS/MS analysis determination
  • 相关文献

参考文献9

  • 1Criscione L, de Gasparo M, Biihlmayer P, et al. Pharmaco- logical profile of valsartan: a potent, orally active, nonpeptide antagonist of the Ang Ⅱ ATl-receptor subtype[J]. Br J Phar- maeol, 1993,110(2) :761-771.
  • 2Thiirmann PA. Valsartan:a novel angiotensin type 1 receptor an- tagonist[J]. Expert Opin Pharmacother, 2000,1(2) : 337- 350.
  • 3Murdoch D, Heel RC. Amlodipine. A review of its pharmaco- dynamic and pharrnacokinetic properties, and therapeutic use in cardiovascular disease[J]. Drugs, 1991,41(3) :478 -505.
  • 4Biihler FR, Hulthen UL, Kiowski W, et al. The place of the calcium antagonist verapamil in antihypertensive therapy[J]. J Cardiovasc Pharmacol, 1982,4(3) : 350 -357.
  • 5Philipp T, Glazer RD, Wernsing M, et al. Initial combination therapy with amlodipine/ valsartan compared with monothera- py in the treatment of hypertension[J]. Journal of the Amcri can Society of Hypertension, 2011,5(5) :417-424.
  • 6杨大龙,丁逸梅,卢定强.复方缬沙坦片中苯磺酸氨氯地平与缬沙坦的HPLC法测定[J].中国医药工业杂志,2011,42(4):292-294. 被引量:3
  • 7惠芳,宋敏,杭太俊.厄贝沙坦氢氯噻嗪片的含量测定和有关物质研究[J].中国新药杂志,2010,19(3):236-242. 被引量:12
  • 8石卫兵,赖宜生,张奕华.苯磺酸氨氯地平的合成研究[J].中国药物化学杂志,2006,16(3):161-164. 被引量:7
  • 9许萌,俞卫峰,高建荣.抗高血压药物缬沙坦的合成方法研究进展[J].广东化工,2011,38(8):78-80. 被引量:6

二级参考文献38

共引文献23

同被引文献78

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部